Courtney Andersen studies the role of estrogen receptor-alpha in ovarian cancer.
Chris Barnes investigates the structural details by which transcription factor activity regulates RNA Polymerase II during the universal process of eukaryotic gene expression.
Soma Jobaggy studies nitrated fatty acid pharmacology and the antioxidant response in hypertensive end-organ damage.
Allison Nagle studies growth factor receptor signaling in breast cancer.
Michael J. Palladino, PhD
Professor & Vice Chair, Academics
7042 Biomedical Science Tower 3
3501 Fifth Ave. Pittsburgh, PA 15260

Email:
mjp44@pitt.edu
Phone: 412-383-5900

Fax: 412-648-7029


Education

BS (Biology), Trinity College, 1997
PhD (Genetics – Biomedical Science), University of Connecticut Health Center, 2000
Postdoctoral Fellow (Neurobiology), University of Wisconsin—Madison, 2003



Research Areas
Drug Discovery
Neuropharmacology
Redox Pharmacology
Metabolic Syndrome Pharmacology
Pharmacology of Cell and Organ Systems
Photo of Michael J. Palladino, PhD

The Palladino lab uses Drosophila (the fruit fly) as a genetic model system, as well as mice and human cell culture to study progressive neurological and neuromuscular disorders. We are currently focusing on elucidating the mechanism by which mutations affecting Na/K ATPase, triose phosphate isomerase (TPI), and ATP6 function result in RDP (rapid-onset dystonia parkinsonism), glycolytic enzymopthy, and mitochondrial encephalomyopathy, respectively. Our research program is directed toward four main goals 1) discovering and characterizing novel pathways that cause progressive disease, 2) understanding the physiological, cellular and molecular dysfunction that causes dysfunction in vivo, 3) understanding the molecular basis of progressive diseases, and 4) using our animal model system to identify novel therapeutic approaches.





Important Publications
Hrizo SL and MJ Palladino.  Hsp70 and Hsp90 mediate proteasomal degradation of TPIsugarkill that underlies pathogenesis.  Neurobiology of Disease 40:676-683, 2010.
Palladino MJ.  Modeling mitochondrial encephalomyopathy in Drosophila.  Neurobiology of Disease 40:40-45, 2010.
Ashmore LJ, SL Hrizo, SM Paul, W Van Voorhies, GJ Beitel and MJ Palladino.  Novel mutations affecting the NA,K ATPase alpha model complex neurological diseases and implicate the sodium pump in increased longevity.  Human Genetics 126:431-447, 2009.
Celotto AM, AC Frank, JL Seigle and MJ Palladino. Drosophila model of human inherited TPI deficiency glycolytic enzymopathy. Genetics 174:1237-1246, 2006.
Celotto AM, AC Frank, SW McGrath, TJ Fergestad, WA Van Voorhies, K Buttle, CA Mannella and MJ Palladino. Mitochondrial encephalomyopathies in drosophila. Journal of Neuroscience 26(3):810-820, 2006.
Palladino MJ, JE Bower, R Kreber and Barry Ganetzky. Neural dysfunction and neurodegeneration in Drosophila Na+/K+ ATPase alpha subunit mutants. Journal of Neuroscience 23(4):1276-1286, 2003.
Palladino MJ, TJ Hadley and B Ganetzky. Temperature-sensitive paralytic mutants are enriched for those causing neurodegeneration in Drosophila.  Genetics 161(3):1197-1208, 2002.
Palladino MJ, LP Keegan, MA O’Connell and RA Reenan. A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity. Cell 102(4):437-449, 2000.

STUDENT NEWS


UPCOMING EVENTS
11/27/2017 8:30 AM Molecular Pharmacology Journal Club
Lloyd Harvey


11/30/2017 12:00 PM Pharmacology & Chemical Biology Seminar Series
Jeffrey L. Brodsky, Ph.D.


12/4/2017 8:30 AM Molecular Pharmacology Journal Club
Andrew Lamade


Pharmacology and Chemical Biology Event Calendar

Program Achievements

Molecular Pharmacology Graduate Program Ranked #2 in National Research Council Rankings

Molecular Pharmacology Graduate Program Ranked #2 in Faculty Scholarly Productivity Index


Outcomes:  Time to disseration, last five graduating clasess:  4.5 years, Completion Rate: 84.8%

Ranked #12 in National of Institute of Health funding of departments of Pharmacology

Ranked in the top 15 in funding for twenty consecutive years




Back to Top